COL8A1 Activators refers to a class of chemical compounds that have the ability to modulate the activity or expression of the COL8A1 gene, which encodes the alpha 1 chain of collagen type VIII. Collagen type VIII is a crucial component of the extracellular matrix, particularly found in tissues such as the cornea of the eye, where it plays a pivotal role in maintaining the structural integrity and transparency of the tissue. The activation of COL8A1 is of significant interest in the context of understanding the regulation of collagen synthesis and extracellular matrix remodeling, which, in turn, has implications for tissue development and maintenance.
These activators, by their nature, exert influence over the production and behavior of collagen type VIII. They may operate through various mechanisms, including direct interaction with regulatory elements within the COL8A1 gene or by affecting upstream signaling pathways that ultimately impact COL8A1 expression. As a result, COL8A1 activators can promote the synthesis and deposition of collagen type VIII, potentially contributing to the structural integrity and functionality of tissues rich in this collagen type. Understanding these compounds and their mechanisms of action can provide insights into how collagen type VIII and the extracellular matrix are regulated, which can be valuable in the context of research and scientific investigations pertaining to tissue development, particularly in the ocular and connective tissue fields.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $46.00 | 5 | |
Serves as a cofactor for enzymes in the collagen synthesis pathway, directly enhancing COL8A1 activation. | ||||||
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $77.00 $270.00 | 55 | |
Indirectly activates COL8A1 by inhibiting matrix metalloproteinases (MMPs) responsible for collagen degradation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Indirectly activates COL8A1 by inhibiting c-Jun N-terminal kinase (JNK), associated with cellular stress responses and collagen metabolism. | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $130.00 $196.00 $274.00 $512.00 $731.00 $1408.00 $2091.00 | 114 | |
Indirectly impacts COL8A1 by inhibiting the STAT3 signaling pathway, involved in tissue repair and extracellular matrix remodeling. | ||||||
Dimethyloxaloylglycine (DMOG) | 89464-63-1 | sc-200755 sc-200755A sc-200755B sc-200755C | 10 mg 50 mg 100 mg 500 mg | $84.00 $301.00 $374.00 $779.00 | 25 | |
Indirectly influences COL8A1 by modulating prolyl hydroxylase activity, impacting collagen stability. | ||||||